Sales rise 6.48% to Rs 2417.50 crore
Net profit of Cadila Healthcare declined 32.15% to Rs 385.50 crore in the quarter ended March 2017 as against Rs 568.20 crore during the previous quarter ended March 2016. Sales rose 6.48% to Rs 2417.50 crore in the quarter ended March 2017 as against Rs 2270.30 crore during the previous quarter ended March 2016.For the full year,net profit declined 23.07% to Rs 1487.70 crore in the year ended March 2017 as against Rs 1933.90 crore during the previous year ended March 2016. Sales rose 1.63% to Rs 9219.80 crore in the year ended March 2017 as against Rs 9071.70 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales2417.502270.30 6 9219.809071.70 2 OPM %19.1824.23 -20.6525.69 - PBDT526.80573.70 -8 1987.202393.30 -17 PBT412.30497.30 -17 1612.202101.20 -23 NP385.50568.20 -32 1487.701933.90 -23
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
